Indexed keywords
AZATHIOPRINE;
CLARITHROMYCIN;
ETHAMBUTOL;
ISONIAZID;
PREDNISONE;
PYRAZINAMIDE;
PYRIDOXINE;
RIFAMPICIN;
ADULT;
ANAMNESIS;
ANTIBIOTIC THERAPY;
ARTICLE;
BACTERIUM CULTURE;
BRONCHOSCOPY;
CASE REPORT;
CLINICAL FEATURE;
CROHN DISEASE;
DIAGNOSTIC PROCEDURE;
FOLLOW UP;
HISTOPATHOLOGY;
HUMAN;
IMMUNE DEFICIENCY;
LABORATORY TEST;
MALE;
MYCOBACTERIOSIS;
MYCOBACTERIUM XENOPEI;
PHYSICAL EXAMINATION;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
RADIODIAGNOSIS;
THORAX RADIOGRAPHY;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS;
AZATHIOPRINE;
CROHN DISEASE;
DIAGNOSIS, DIFFERENTIAL;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSIVE AGENTS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
MYCOBACTERIUM INFECTIONS, ATYPICAL;
MYCOBACTERIUM XENOPI;
OPPORTUNISTIC INFECTIONS;
PREDNISONE;
TOMOGRAPHY, X-RAY COMPUTED;
TUBERCULOSIS, PULMONARY;
1
0020190052
Mycobacterium xenopi: Infection in an immunocompromised host
Damsker B, Bottone EJ, Deligdisch L. Mycobacterium xenopi: infection in an immunocompromised host. Hum Pathol 1982;13:866-70.
(1982)
Hum Pathol , vol.13
, pp. 866-870
Damsker, B.1
Bottone, E.J.2
Deligdisch, L.3
2
0021351072
Pulmonary infection with Mycobacterium xenopi: Review of treatment and response
Banks J, Hunter AM, Campbell IA, et al. Pulmonary infection with Mycobacterium xenopi: review of treatment and response. Thorax 1984;39:376-82.
(1984)
Thorax , vol.39
, pp. 376-382
Banks, J.1
Hunter, A.M.2
Campbell, I.A.3
3
0031049746
Mycobacterium xenopi: Innocent bystander or emerging pathogen?
Jiva TM, Jacoby HM, Weymouth LA, et al. Mycobacterium xenopi: innocent bystander or emerging pathogen? Clin Infect Dis 1997;24:226-32.
(1997)
Clin Infect Dis , vol.24
, pp. 226-232
Jiva, T.M.1
Jacoby, H.M.2
Weymouth, L.A.3
5
0020539124
Clinical review of pulmonary disease caused by Mycobacterium xenopi
Smith J, Citron KM. Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax 1983;38:373-7.
(1983)
Thorax , vol.38
, pp. 373-377
Smith, J.1
Citron, K.M.2
6
0033228319
Pulmonary nontuberculous mycobacterium infection: Radiologic manifestations
Erasmus JJ, McAdams HP, Farrell MA, et al. Pulmonary nontuberculous mycobacterium infection: radiologic manifestations. Radiographics 1999;19:1487-505.
(1999)
Radiographics , vol.19
, pp. 1487-1505
Erasmus, J.J.1
McAdams, H.P.2
Farrell, M.A.3
7
0019365287
Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi
Costrini AM, Mahler DA, Gross WM, et al. Clinical and roentgenographic features of nosocomial pulmonary disease due to Mycobacterium xenopi. Am Rev Respir Dis 1981;213:104-9.
(1981)
Am Rev Respir Dis , vol.213
, pp. 104-109
Costrini, A.M.1
Mahler, D.A.2
Gross, W.M.3
8
0033980624
Clinical and radiological characteristics of lung disease in inflammatory bowel disease
Mahadeva R, Walsh G, Flower CDR, et al. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000;15:41-8.
(2000)
Eur Respir J , vol.15
, pp. 41-48
Mahadeva, R.1
Walsh, G.2
Flower, C.D.R.3
9
0034881830
Granulomatous lung masses in an elderly patient with inactive Crohn's disease
Lucero PF, Frey WC, Shaffer RT, et al. Granulomatous lung masses in an elderly patient with inactive Crohn's disease. Inflamm Bowel Dis 2001;7:256-9.
(2001)
Inflamm Bowel Dis , vol.7
, pp. 256-259
Lucero, P.F.1
Frey, W.C.2
Shaffer, R.T.3
10
0035089052
First randomised trial of treatment for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HlV negative patients: Rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
Research Committee of the British Thoracic Society. First randomised trial of treatment for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HlV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001;56:167-72.
(2001)
Thorax , vol.56
, pp. 167-172
